Cautious. Hengrui Pharmaceuticals scores well on value metrics (70/100) with reasonable multiples, but growth stalls at 39/100—indicating mature, slow-expansion pharma dynamics. Leadership alignment (62.5/100) is moderate; no founder-CEO anchor mitigates execution risk. The Vulnerable profile reflects structural exposure to China regulatory tightening and generic competition, eroding margin durability despite near-term valuation appeal.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for HERALD INVESTMENT TRUST PLC ORD:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 49/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates HERALD INVESTMENT TRUST PLC ORD (HRI.L) at 49/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. Hengrui Pharmaceuticals scores well on value metrics (70/100) with reasonable multiples, but growth stalls at 39/100—indicating mature, slow-expansion pharma dynamics. Leadership alignment (62.5/100) is moderate; no founder-CEO an
HRI.L's current Stocky Verdict is 49/100, placing it in the "Cautious" band. This composite combines a 70/100 Compounder score, 63/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for HERALD INVESTMENT TRUST PLC ORD yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
HERALD INVESTMENT TRUST PLC ORD scores 63/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
HERALD INVESTMENT TRUST PLC ORD's Vulnerability Profile scores 0/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to HERALD INVESTMENT TRUST PLC ORD.
Sign up free and unlock the full analysis on HRI.L — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
Or jump straight to the interactive dashboard for HRI.L in the app.
